You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 5 No. 3, September 1961 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (19)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Demyelinating Disease of the Brain in Chronic Lymphatic Leukemia

Occurrence of a Case in the Husband of a Patient with Multiple Sclerosis

WILLIAM A. SIBLEY, M.D.; AUSTIN S. WEISBERGER, M.D.

Arch Neurol. 1961;5(3):300-307.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Certain neurological complications appearing during the course of leukemia and related disorders are not infrequent. The occurrence of cerebral hemorrhage in the leukemias, often as a terminal event, is usually easily recognized. Involvement of the spinal epidural space by Hodgkin's disease and lymphosarcoma, resulting in paraplegia, is also a relatively common phenomenon. Focal symptomatology developing as a result of direct invasion of the brain by leukemic or lymphomatous tissue is quite uncommon; however, even this complication has been reported more frequently recently, especially in the acute leukemias managed by modern chemotherapeutic methods.1

An interesting but less widely known complication of the lymphomas is a demyelinating disease of the brain, recently described by Astrom, Mancall, and Richardson.2 This disease, termed "progressive multifocal leukoencephalopathy," is manifested clinically by signs of diffuse brain involvement progressing rapidly, without remission, to a fatal termination within weeks or months. It has occurred predominantly in . . . [Full Text PDF of this Article]


Author Affiliations

CLEVELAND

From the Division of Neurology, Department of Medicine, Western Reserve University School of Medicine, and University Hospitals of Cleveland.


Footnotes

Received for publication June 8, 1961.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1961 American Medical Association. All Rights Reserved.